Connect with us

JAMMU & KASHMIR

Blood pressure medicines don’t increase risk of COVID: DAK | KNO

Published

on

kno news

Srinagar, June 01 (KNO): Doctors Association Kashmir (DAK) on Monday said blood pressure medicines do not increase the risk of infection, serious illness or death from the novel coronavirus. “It is perfectly safe to continue your blood pressure medication during the Covid pandemic,” said DAK President Dr Nisar-u-Hassan in a statement issued to news agency—Kashmir News Observer (KNO) “People have apprehensions that ACE inhibitors and ARBs, two classes of drugs that are widely prescribed for high blood pressure increase the risk of Covid infection and the likelihood of severe illness among those infected with the novel virus,” he said. “ACE inhibitors include enalapril, lisinopril, captopril and other drugs with generic names ending in –pril; ARBs include Losartan, telmisartan, olmesartan and other generic drugs ending in –sartan,” he added. Dr Nisar said speculations about worse outcomes among patients on these medications during the Covid pandemic have caused widespread anxiety among patients and their care providers. Quoting three studies published in New England Journal of Medicine, Dr Nisar said no link was found between the use of blood pressure drugs and coronavirus infection. “It was also revealed that patients on these drugs faced no increase in risk of becoming severely ill with Covid infection,” he added. Dr Nisar said the articles showed no association between use of the two classes of blood pressure drugs of concern and dying from COVID-19. “In fact, some studies suggest that these drugs might reduce lung injury in people infected with the novel virus,” he said. Dr Nisar said it is vitally important to keep your blood pressure well controlled and take medication as advised. “Having high blood pressure has been associated with higher rate of dying from Covid-19,” he said. “People should stick with their blood pressure medication because high blood pressure is a risk factor for heart attack, stroke and kidney failure,” said Dr Nisar –(KNO)

Trending

TOP STORIES1 hours ago

Census 2027: Early headcount in J&K’s snow‑bound areas from September 01 | KNO

TOP STORIES1 hours ago

Amarnath Yatra crosses 4.67 lakh pilgrim mark | KNO

TOP STORIES1 hours ago

Security tightened across J&K ahead of Aug 5, protests barred in Kashmir, Jammu on high alert | KNO

TOP STORIES2 hours ago

Society must respect artisans, say Budgam's National Handloom Awardees ahead of President's Honour | KNO

TOP STORIES2 hours ago

Cabinet clears Gulmarg hotel outsourcing, IT park, land transfers, JKAS promotions | KNO

TOP STORIES2 hours ago

Indian Corporate Law Service cornerstone of India’s economic credibility: LG Sinha | KNO

TOP STORIES2 hours ago

Kashmir must reclaim its place on India’s Golf map: CM Omar | KNO

TOP STORIES2 hours ago

India rejects PoJK polls, asks Pakistan to act against terror infrastructure | KNO

TOP STORIES2 hours ago

Govt adopts multi-pronged strategy to curb cross-border infiltration: MHA | KNO

TOP STORIES2 hours ago

Indian Railways witnessed massive transformation under PM Modi’s rule: LG Sinha | KNO

TOP STORIES2 hours ago

Jantar Mantar protest reflected people’s resolve for J&K statehood: Sakina Itoo | KNO

TOP STORIES2 hours ago

Article 370 abrogation brought peace to J&K: Ashok Koul | KNO

TOP STORIES2 hours ago

Centre highlights infrastructure, tourism, healthcare push for J&K, Ladakh | KNO

TOP STORIES2 hours ago

Zero tolerance policy against drug traffickers in force, Centre tells Lok Sabha | KNO

TOP STORIES2 hours ago

J&K records 2,182 child kidnapping cases between 2020-2024; 2, 95% recovered | KNO

TOP STORIES2 hours ago

J&K records 3 heatstroke cases but no deaths in 2026 so far: MHA | KNO

TOP STORIES2 hours ago

‘J&K gets Rs 6,562.57 crore central share under PMGSY since 2020-21; Rs 6,497.91 crore expenditure recorded’ | KNO

Copyright © 2021